WO2000072858A1 - Composition d'additif alimentaire destine au traitement preventif de la coccidiose - Google Patents
Composition d'additif alimentaire destine au traitement preventif de la coccidiose Download PDFInfo
- Publication number
- WO2000072858A1 WO2000072858A1 PCT/FR2000/001419 FR0001419W WO0072858A1 WO 2000072858 A1 WO2000072858 A1 WO 2000072858A1 FR 0001419 W FR0001419 W FR 0001419W WO 0072858 A1 WO0072858 A1 WO 0072858A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- tannin
- food additive
- coccidiosis
- tannins
- food
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 63
- 235000013373 food additive Nutrition 0.000 title claims abstract description 28
- 239000002778 food additive Substances 0.000 title claims abstract description 28
- 208000003495 Coccidiosis Diseases 0.000 title claims abstract description 24
- 238000011282 treatment Methods 0.000 title claims abstract description 24
- 206010023076 Isosporiasis Diseases 0.000 title claims abstract description 23
- 230000003449 preventive effect Effects 0.000 title claims abstract description 19
- 229920001864 tannin Polymers 0.000 claims abstract description 72
- 239000001648 tannin Substances 0.000 claims abstract description 72
- 235000018553 tannin Nutrition 0.000 claims abstract description 72
- 235000016709 nutrition Nutrition 0.000 claims abstract description 19
- 239000004480 active ingredient Substances 0.000 claims abstract description 11
- 241001070941 Castanea Species 0.000 claims description 14
- 235000014036 Castanea Nutrition 0.000 claims description 14
- 239000002023 wood Substances 0.000 claims description 10
- 238000002386 leaching Methods 0.000 claims description 3
- 239000000843 powder Substances 0.000 claims description 2
- 235000013305 food Nutrition 0.000 description 22
- 241000287828 Gallus gallus Species 0.000 description 16
- 235000013330 chicken meat Nutrition 0.000 description 16
- 235000013601 eggs Nutrition 0.000 description 11
- 241000304695 Eimeria sp. Species 0.000 description 10
- 241000223924 Eimeria Species 0.000 description 9
- 241000607142 Salmonella Species 0.000 description 9
- 210000003608 fece Anatomy 0.000 description 8
- 241001465754 Metazoa Species 0.000 description 7
- 239000000341 volatile oil Substances 0.000 description 7
- LRBQNJMCXXYXIU-QWKBTXIPSA-N gallotannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@H]2[C@@H]([C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-QWKBTXIPSA-N 0.000 description 6
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 6
- 241000224483 Coccidia Species 0.000 description 5
- 239000003242 anti bacterial agent Substances 0.000 description 5
- 229940088710 antibiotic agent Drugs 0.000 description 5
- 235000019786 weight gain Nutrition 0.000 description 5
- 230000004584 weight gain Effects 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 238000003860 storage Methods 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 241000271566 Aves Species 0.000 description 3
- 239000005844 Thymol Substances 0.000 description 3
- 238000011109 contamination Methods 0.000 description 3
- 210000001035 gastrointestinal tract Anatomy 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 244000144977 poultry Species 0.000 description 3
- 235000013594 poultry meat Nutrition 0.000 description 3
- 230000035755 proliferation Effects 0.000 description 3
- 229960000790 thymol Drugs 0.000 description 3
- 241000283690 Bos taurus Species 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 241000209140 Triticum Species 0.000 description 2
- 235000021307 Triticum Nutrition 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- 230000007717 exclusion Effects 0.000 description 2
- 230000037406 food intake Effects 0.000 description 2
- LHGVFZTZFXWLCP-UHFFFAOYSA-N guaiacol Chemical compound COC1=CC=CC=C1O LHGVFZTZFXWLCP-UHFFFAOYSA-N 0.000 description 2
- 230000012447 hatching Effects 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 230000001937 non-anti-biotic effect Effects 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 235000012424 soybean oil Nutrition 0.000 description 2
- 239000003549 soybean oil Substances 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 238000007619 statistical method Methods 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 239000001074 1-methoxy-4-[(E)-prop-1-enyl]benzene Substances 0.000 description 1
- ZSZFUDFOPOMEET-UHFFFAOYSA-N 2-(4-chlorophenyl)-2-[2,6-dichloro-4-(3,5-dioxo-1,2,4-triazin-2-yl)phenyl]acetonitrile Chemical compound C1=CC(Cl)=CC=C1C(C#N)C1=C(Cl)C=C(N2C(NC(=O)C=N2)=O)C=C1Cl ZSZFUDFOPOMEET-UHFFFAOYSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 235000019737 Animal fat Nutrition 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- 239000004470 DL Methionine Substances 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 240000003183 Manihot esculenta Species 0.000 description 1
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 description 1
- 229930191564 Monensin Natural products 0.000 description 1
- GAOZTHIDHYLHMS-UHFFFAOYSA-N Monensin A Natural products O1C(CC)(C2C(CC(O2)C2C(CC(C)C(O)(CO)O2)C)C)CCC1C(O1)(C)CCC21CC(O)C(C)C(C(C)C(OC)C(C)C(O)=O)O2 GAOZTHIDHYLHMS-UHFFFAOYSA-N 0.000 description 1
- MVTQIFVKRXBCHS-SMMNFGSLSA-N N-[(3S,6S,12R,15S,16R,19S,22S)-3-benzyl-12-ethyl-4,16-dimethyl-2,5,11,14,18,21,24-heptaoxo-19-phenyl-17-oxa-1,4,10,13,20-pentazatricyclo[20.4.0.06,10]hexacosan-15-yl]-3-hydroxypyridine-2-carboxamide (10R,11R,12E,17E,19E,21S)-21-hydroxy-11,19-dimethyl-10-propan-2-yl-9,26-dioxa-3,15,28-triazatricyclo[23.2.1.03,7]octacosa-1(27),6,12,17,19,25(28)-hexaene-2,8,14,23-tetrone Chemical compound CC(C)[C@H]1OC(=O)C2=CCCN2C(=O)c2coc(CC(=O)C[C@H](O)\C=C(/C)\C=C\CNC(=O)\C=C\[C@H]1C)n2.CC[C@H]1NC(=O)[C@@H](NC(=O)c2ncccc2O)[C@@H](C)OC(=O)[C@@H](NC(=O)[C@@H]2CC(=O)CCN2C(=O)[C@H](Cc2ccccc2)N(C)C(=O)[C@@H]2CCCN2C1=O)c1ccccc1 MVTQIFVKRXBCHS-SMMNFGSLSA-N 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- 235000019764 Soybean Meal Nutrition 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 108010080702 Virginiamycin Proteins 0.000 description 1
- 239000004188 Virginiamycin Substances 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 235000021053 average weight gain Nutrition 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- RECUKUPTGUEGMW-UHFFFAOYSA-N carvacrol Chemical compound CC(C)C1=CC=C(C)C(O)=C1 RECUKUPTGUEGMW-UHFFFAOYSA-N 0.000 description 1
- HHTWOMMSBMNRKP-UHFFFAOYSA-N carvacrol Natural products CC(=C)C1=CC=C(C)C(O)=C1 HHTWOMMSBMNRKP-UHFFFAOYSA-N 0.000 description 1
- 235000007746 carvacrol Nutrition 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 150000001896 cresols Chemical class 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 229960000248 diclazuril Drugs 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000005188 flotation Methods 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 229960001867 guaiacol Drugs 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 239000002555 ionophore Substances 0.000 description 1
- 230000000236 ionophoric effect Effects 0.000 description 1
- WYXXLXHHWYNKJF-UHFFFAOYSA-N isocarvacrol Natural products CC(C)C1=CC=C(O)C(C)=C1 WYXXLXHHWYNKJF-UHFFFAOYSA-N 0.000 description 1
- FFEARJCKVFRZRR-UHFFFAOYSA-N methionine Chemical compound CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 235000006109 methionine Nutrition 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000003641 microbiacidal effect Effects 0.000 description 1
- 238000013048 microbiological method Methods 0.000 description 1
- 229960005358 monensin Drugs 0.000 description 1
- GAOZTHIDHYLHMS-KEOBGNEYSA-N monensin A Chemical compound C([C@@](O1)(C)[C@H]2CC[C@@](O2)(CC)[C@H]2[C@H](C[C@@H](O2)[C@@H]2[C@H](C[C@@H](C)[C@](O)(CO)O2)C)C)C[C@@]21C[C@H](O)[C@@H](C)[C@@H]([C@@H](C)[C@@H](OC)[C@H](C)C(O)=O)O2 GAOZTHIDHYLHMS-KEOBGNEYSA-N 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 210000003250 oocyst Anatomy 0.000 description 1
- RUVINXPYWBROJD-UHFFFAOYSA-N para-methoxyphenyl Natural products COC1=CC=C(C=CC)C=C1 RUVINXPYWBROJD-UHFFFAOYSA-N 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000013777 protein digestion Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000003307 slaughter Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000004455 soybean meal Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- RUVINXPYWBROJD-ONEGZZNKSA-N trans-anethole Chemical compound COC1=CC=C(\C=C\C)C=C1 RUVINXPYWBROJD-ONEGZZNKSA-N 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 229960003842 virginiamycin Drugs 0.000 description 1
- 235000019373 virginiamycin Nutrition 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/49—Fagaceae (Beech family), e.g. oak or chestnut
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
Definitions
- the present invention relates to a food additive composition for the preventive treatment of coccidiosis.
- the present invention also relates to a nutritional composition containing this additive and which makes it possible to treat coccidiosis as a preventive measure.
- Coccidiosis is a disease of the intestines, the pathogens of which are protozoa which gradually invade the intestinal epithelium, preventing the absorption of nutrients and causing weight loss in the contaminated individual, which may even lead to death.
- Coccidioses affect both mammals, such as cattle or humans, as well as birds, in which, with certain highly pathogenic species, they can cause death. In humans, it can also be dangerous, especially if the immune system is weakened.
- Synthetic antibiotics, ionophores and other non-antibiotic synthetics are commonly used to treat coccidiosis.
- the document WO 96/13175 recommends in the case of poultry, the use of a food additive containing a mixture of cresols, guaiacol, thymol, anethol, eugenol, capsaine and tannin in combination with an emulsifying agent.
- This mixture does not have a microbicidal effect on sporulated coccidia oocysts but, on the other hand, blocks reinfestation after the first passage of coccidia in the digestive tract of poultry.
- composition of food additive based on natural essential oils easily assimilated or degradable by the body has few or no side effects and above all does not cause any accumulation of active substances in the tissues.
- the object of the present invention is therefore to propose a food additive composition for the preventive treatment of coccidiosis, the manufacture of which is economically advantageous.
- a food additive composition intended for the preventive treatment of coccidiosis which typically according to the invention exclusively contains a tannin or a mixture of tannins as active ingredient.
- the food additive therefore contains as sole active ingredient one or more tannins, in particular to the exclusion of essential oils. It is therefore the merit of the Applicant to have demonstrated that the tannin alone is particularly active in the preventive treatment of coccidiosis.
- the known food compositions intended for the treatment of coccidiosis all contain essential oils.
- the present invention also relates to a food additive composition intended for the preventive treatment of coccidiosis which typically contains exclusively a tannin or a mixture of tannins as active ingredient chosen from tannins of oak and chestnut.
- a food additive composition intended for the preventive treatment of coccidiosis which typically contains exclusively a tannin or a mixture of tannins as active ingredient chosen from tannins of oak and chestnut.
- the Applicant has also demonstrated that these two tannins prove to be particularly stable in particular to heat and to light.
- the use of the two aforementioned tannins, alone or as a mixture makes it possible to obtain a particularly stable food additive whatever the duration and the conditions of its storage.
- the compositions containing essential oils are in fact particularly sensitive to light and to heat, which limits their duration of storage or imposes storage conditions which are difficult to achieve or to maintain in particular on operating sites such as, for example, poultry farm sites.
- the Applicant has also demonstrated that these two tannins form bonds with proteins which are easily hydrolyzable at the pH prevailing in the digestive tract of animals and in particular chicken.
- the use of the two aforementioned particular tannins therefore makes it possible to obtain a composition of food additive whose preventive activity on coccidiosis is stable whatever the duration and the storage conditions of the composition and which, moreover , born not block protein digestion. It is therefore the merit of the Applicant to have chosen the two aforementioned particular tannins which have both good stability and do not block the assimilation of proteins.
- the origin of the tannin or tannins in the mixture of tannins is not limited according to the invention. These tannins can be synthetic or natural.
- the tannin or tannins in the mixture are obtained by leaching the wood, preferably oak or chestnut.
- the form in which the tannin is used is not limitative of the invention. It is possible, for example, to use a particularly aqueous solution containing the tannin (s). Preferably, the tannin or tannins are used in the form of dry powder which facilitates their mixing to obtain a nutritional composition.
- the present invention also relates to a nutritional composition intended for the preventive treatment of coccidiosis, which typically contains, as the sole active ingredient, the food additive composition of the invention.
- the nutritional composition of the invention contains at least 0.1% by mass of tannin (s) provided by the food additive of the invention.
- tannin s
- the Applicant has in fact demonstrated that this percentage ensures real effectiveness of the nutritional composition on the preventive treatment of coccidiosis.
- the nutritional composition of the invention contains at least 0.150% by tannin mass (s) provided by the food additive of the invention.
- the nutritional composition of the invention contains between 0.1% and 1% by tannin mass (s) provided by the food additive of the invention.
- the nutritional composition of the invention contains between 0.150% and 1% by tannin mass (s) provided by the food additive of the invention.
- Such amounts of tannins confer satisfactory activity on the food composition of the invention; moreover, their links with proteins remain easily hydrolyzable in the digestive tract and therefore do not prevent the assimilation of proteins.
- the tannin used in the particular examples which follow is a tannin or a mixture of tannins extracted from chestnut wood.
- Preparation of the tannin The tannin used is obtained by steam leaching of chestnut wood shavings. The solution is then evaporated and atomized to obtain a dry extract which represents 95% (+ - 1%) by mass of the initial aqueous solution. This dry extract contains 77% by mass of chestnut tannin (s). The remaining 23% of the dry extract consists of water (5%), ash and tannin precursor sugars (18%).
- This chestnut wood extract is mixed with the chicken food so as to obtain a mixture containing 0.2% by mass of chestnut wood extract with 77% tannin (s) or a percentage of 0.154% by mass of chestnut tannin (s).
- Each treatment was carried out on three groups of 30 battery chickens, male and female of the breed "Ross 208", aged 360 days.
- the chickens were fed with the nutritional compositions indicated in table 1, under standard temperature, lighting and ventilation conditions.
- the departure period extends from 0 to two weeks after the start of the experience while the period fattening period extends from 2 to 6 weeks after the start of the experiment.
- the chickens have also been vaccinated against the Newcasttle virus (by Hitchner spray) and against bronchitis (by H120 spray). Food and water were provided ad libitum.
- the nutritional compositions also include agents preventing the proliferation of the coccidia contained in the “Premix” mixture.
- Table 2 groups together the four groups and the percentage of chestnut extract which was respectively incorporated into the nutritional compositions.
- Table 3 provides a statistical analysis of the results.
- the chicks were divided into four main groups. Each of these main groups was then divided into two subgroups of 24 chicks (respectively 1 CS, 1TS, 2CS, 2TS, 3CC, 3TC, 4CC, 4TC) which allows to combine subgroups of chicks having received chestnut extract in the same cage but in separate compartments. This strategy makes it possible to determine the influence of environmental conditions on the statistical analyzes of the results obtained.
- the animals of groups 1TS, 2TS, 3TC and 4TC were fed with a food containing 0.2% by weight of chestnut extract.
- the animals of groups 1 CS, 2CS, 3CC and 4CC were fed with the same food but not containing the extract of chestnut.
- the droppings of the chicks are collected every five days on paper placed under the cages. Micro-biological methods used The action of the chestnut extract on the ejection of Eimeria sp. was studied on chick droppings collected five days apart. The droppings are then quantitatively analyzed by flotation to determine the number of Eimeria sp eggs they contain. Detection of Eimeria sp in chicken droppings
- the filtrate is homogenized by successive transfer to another beaker (repeated 10 times) and introduced into a McMaster chamber using a pasteur pipette.
- the chamber is left to stand for 2 minutes and then placed under a microscope.
- the magnification used is 100x.
- the eggs of Eimeria sp are then counted
- the total number of Eimeria sp. is obtained by multiplying by 50 the total number of eggs of Eimeria sp. determined in the room. The sensitivity of the test is 50.
- Table 4 represents the subdivisions within each sub-group; the chicks are placed in boxes of four compartments each containing 6 birds. Groups 1 and 2 were further contaminated by injection of 104 cfu / chick of Salmonella Entendis PT4 (NIDO 76Sa88) by gavage at the age of 6 days.
- Graph 1 represents the total number of Eimeria sp eggs collected respectively for the control group and the groups treated with tannin.
- Graph 2 represents the number of Eimeria sp eggs collected from the droppings of chickens contaminated with Salmonella. We note that in this case, the chicks which ingested tannin are less contaminated by Eimeria sp than the chicks which did not ingest tannin. Table 5 groups together the number of eggs collected in the droppings of each of the groups defined in Table 4.
- Graph 4 represents the weight gain of the different groups of 55-day-old chicks. It is noted that the CS and TS groups which have absorbed tannin have a greater average weight gain than the groups which have not been treated with tannin. So it would seem that, even in the case of contamination by Saimonella, the ingestion of tannin favors the weight gain of individuals without nevertheless having a direct influence on Salmonella itself.
- the Premix provides 100 mg of monensin (for the period of 0-2 weeks), 1 mg of diclazuril (-Clinacox) (for the period of 2-6 weeks) and 15 mg of virginiamycin per kg of food.
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU50816/00A AU5081600A (en) | 1999-05-28 | 2000-05-25 | Food additive composition for preventive treatment of coccidiosis |
BR0011020-5A BR0011020A (pt) | 1999-05-28 | 2000-05-25 | Composição de aditivo alimentar para o tratamento preventivo de coccidiose |
EP00935257A EP1181028A1 (fr) | 1999-05-28 | 2000-05-25 | Composition d'additif alimentaire destine au traitement preventif de la coccidiose |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR99/06917 | 1999-05-28 | ||
FR9906917A FR2794024B1 (fr) | 1999-05-28 | 1999-05-28 | Preparation a base de tanin(s) destinee au traitement de la coccidiose |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2000072858A1 true WO2000072858A1 (fr) | 2000-12-07 |
Family
ID=9546251
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/FR2000/001419 WO2000072858A1 (fr) | 1999-05-28 | 2000-05-25 | Composition d'additif alimentaire destine au traitement preventif de la coccidiose |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1181028A1 (fi) |
AU (1) | AU5081600A (fi) |
BR (1) | BR0011020A (fi) |
FR (1) | FR2794024B1 (fi) |
WO (1) | WO2000072858A1 (fi) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2510808A1 (fr) * | 2011-04-11 | 2012-10-17 | T L | Utilisation de tanins hydrolysables dans l'alimentation animale |
FR3124947A1 (fr) * | 2021-07-12 | 2023-01-13 | Societe D'exploitation De Produits Pour Les Industries Chimiques Seppic | Composition ingérable (Ci) pour une utilisation dans le traitement d’un trouble cutané induit par un trouble intestinal |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996013175A1 (fr) * | 1994-10-26 | 1996-05-09 | Crina S.A. | Composition d'additif pour aliments destines a la volaille |
WO1997007812A1 (en) * | 1995-08-25 | 1997-03-06 | Jasna Mandic | Production process of the ecological pharmaceutical compositions in the veterinary medical field |
-
1999
- 1999-05-28 FR FR9906917A patent/FR2794024B1/fr not_active Expired - Fee Related
-
2000
- 2000-05-25 WO PCT/FR2000/001419 patent/WO2000072858A1/fr not_active Application Discontinuation
- 2000-05-25 AU AU50816/00A patent/AU5081600A/en not_active Abandoned
- 2000-05-25 EP EP00935257A patent/EP1181028A1/fr not_active Withdrawn
- 2000-05-25 BR BR0011020-5A patent/BR0011020A/pt not_active IP Right Cessation
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996013175A1 (fr) * | 1994-10-26 | 1996-05-09 | Crina S.A. | Composition d'additif pour aliments destines a la volaille |
WO1997007812A1 (en) * | 1995-08-25 | 1997-03-06 | Jasna Mandic | Production process of the ecological pharmaceutical compositions in the veterinary medical field |
Also Published As
Publication number | Publication date |
---|---|
BR0011020A (pt) | 2002-08-27 |
AU5081600A (en) | 2000-12-18 |
EP1181028A1 (fr) | 2002-02-27 |
FR2794024A1 (fr) | 2000-12-01 |
FR2794024B1 (fr) | 2001-08-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Freeland et al. | Strategies in herbivory by mammals: the role of plant secondary compounds | |
Aly et al. | Effect of naturally contaminated feed with aflatoxins on performance of laying hens and the carryover of aflatoxin B1 residues in table eggs | |
EP2938188B1 (fr) | Complexe moléculaire détoxifiant et antimicrobien | |
BG62757B1 (bg) | Фармацевтични състави на основата на растителни етерични масла за хуманната и ветеринарната медицина | |
Abd El-Hack et al. | Pharmacological, nutritional and antimicrobial uses of Moringa oleifera Lam. leaves in poultry nutrition: an updated knowledge | |
EP3558294B1 (fr) | Composition à base de composés thiosulfinate et/ou de thiosulfonate pour son utilisation dans la prévention des infections bactériennes chez les animaux aquatiques | |
EP0786944B1 (fr) | Composition d'additif pour aliments destines a la volaille | |
Desoky et al. | Effects of ginger and bee propolis on the performance, carcass characteristics and blood constituents of growing Japanese quail | |
FR2833813A1 (fr) | Complement alimentaire destine a l'animal | |
Puvača et al. | Influence of tea tree (Melaleuca alternifolia) essential oil as feed supplement on production traits, blood oxidative status and treatment of coccidiosis in laying hens. | |
EP1181028A1 (fr) | Composition d'additif alimentaire destine au traitement preventif de la coccidiose | |
JP2018509161A (ja) | 生物活性動物用飼料中における古細菌、その組成物を製造する方法、および前記組成物を用いる方法 | |
FR2765078A1 (fr) | Procede d'amelioration de l'efficacite d'un probiotique, preparation d'additifs alimentaires et aliments pour animaux la contenant | |
FR3026643A1 (fr) | Aliment complementaire a base d'extraits de plantes aromatiques pour la gestion de la dermatite digitee ou mortellaro par la gestion du stress abiotique | |
JP2023525883A (ja) | コクシジウム症の治療へのtlr4モジュレーターの使用 | |
Chongwe | The effect of moringa supplementation on growth and health of indigenous Zambian chickens | |
BE1027687B1 (nl) | Dierenvoer, gebruik daarvan en werkwijze voor het produceren van het genoemde dierenvoer | |
Ayodele et al. | Nutritional Evaluation of Moringa oleifera Leaves and the Effect of Its Bio-fortification with Animal Feed on Physical Changes and Organ Weights in Male Albino Rats | |
Puvača et al. | Utjecaj esencijalnog ulja čajevca (Melaleuca alternifolia) kao dodatka prehrani na proizvodna svojstva, oksidacijski status krvi i liječenje kokcidioze u kokoši nesilica | |
WO2020221867A1 (fr) | Composition contre les ectoparasites | |
FR3134312A1 (fr) | Extrait de Parois Cellulaires de Levure Saccharomyces Cerevisiae Riche en -Glucanes dans la Prévention des Effets Toxiques de la Mycotoxine Déoxynivalénol (DON) | |
WO2020002716A1 (fr) | Composition antiparasitaire comprenant de la βεταϊνε et des extraits d'echinacea purpurea et de curcuma longa | |
BÖLÜKBAŞI et al. | The Effect of Propolis Addition Into Laying Hen Diet on Performance, Serum Lipid Profile and Liver Fat Rate | |
Rakita et al. | Mahmoud Radwan1, Mahmoud A. El-Sharkawy2, Mohammed A. Negm3, Amaal Mohammadein4, Jamila S. Al Malki4, Asma W. Al-Thomali4, Ahmed M. Mohamed5, Shahd Yassir6 and Mansour AE Bashar1 | |
El-Aziz et al. | Bee Products for Poultry and Rabbits: Current Challenges and Perspectives. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2000935257 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 09980001 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 2000935257 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2000935257 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: JP |